Scientists have used artificial intelligence to design 16 entirely novel viruses from scratch by training the AI on DNA sequences, marking the first time this has been achieved.
While the viruses pose no immediate threat to humans, the breakthrough raises questions about both potential medical breakthroughs and the risk of creating biological weapons.
In parallel regulatory news, Meta has been hit with a $567 million fine from a New Mexico judge over child safety harms, with the total fine now reaching $942 million after a jury found the company had misled users about child safety practices.
What happened
Scientists trained AI on DNA sequences to design new genomes, producing 16 novel viruses that pose no threat to people. Separately, a New Mexico judge fined Meta $567 million over harms to children, bringing the total fine in the landmark trial to $942 million after a jury found Meta had misled users over child safety.
Why it matters
AI-designed viruses could lead to medical breakthroughs, but experts note uncertainty about risks from pathogens never seen before—as Dr Moritz Hanke of Johns Hopkins Center for Health Security put it, "What is the risk of what I've never seen before?" The Meta ruling underscores continued regulatory pressure on platforms over child protection practices.
What to watch
The AI-designed viruses carry dual-use potential (medical advances or biological weapons); researchers are still assessing risks. Meta's combined $942 million in fines signals escalating financial consequences for child safety violations.
Researchers have achieved a significant milestone in artificial intelligence capabilities by training AI on DNA sequences to design new virus genomes from scratch. The effort produced 16 novel viruses, which according to reports pose no threat to people. However, the achievement raises profound questions about both opportunity and risk. Scientists note that the AI-designed viruses could lead to medical breakthroughs, but could also potentially be used to create biological weapons. Dr Moritz Hanke, a fellow at the Johns Hopkins Center for Health Security, articulated the core dilemma when speaking to the New York Times: "What is the risk of what I've never seen before?" His question underscores that there is no scientific consensus on the dangers posed by pathogens that have never existed in nature and have not been studied by the research community.
In regulatory news, Meta has faced its largest child safety penalty to date. A New Mexico judge imposed a $567 million fine against the company over harms to children. This ruling constitutes the second phase of a landmark trial that Meta lost. A jury had found that Meta misled users regarding child safety. The combined penalties across both phases of the case now total $942 million, signaling an escalation in financial consequences for platform companies found to have failed in child protection practices.
The article highlights two distinct but complementary stories about AI's growing power and the regulatory response to technology platforms. The virus-design breakthrough represents a milestone in AI capability—the first time machine learning has been used to generate entirely novel pathogens from genetic sequences. Scientists acknowledge dual-use potential: the technology could unlock medical discoveries, yet also opens a path to biological weapon creation. The uncertainty itself is notable; Dr Moritz Hanke's quote captures the regulatory and scientific dilemma: there is no consensus on the dangers of a pathogen no human has encountered before, making risk assessment difficult.
The Meta fine reflects a parallel theme: regulators are moving from warnings to enforcement against technology companies over child safety. At $942 million in total penalties, the ruling signals that courts and regulators view misleading users about safety protections as a material violation. Both stories—the AI breakthrough and the Meta penalty—underscore how rapidly AI and platform capabilities are advancing, and how the legal and scientific frameworks to govern them are still being established.
AI-summarized, only the topics you pick — one digest a day via Email, Slack, or Discord.
Free · takes 30 seconds · unsubscribe anytime
Ask AI anything about this article. Q&As are published on this page for other readers too.
Novo Nordisk has entered a strategic partnership with Amazon Web Services (AWS) to accelerate drug discovery u…
Meta CEO Mark Zuckerberg published a 6,500-word essay Monday outlining his vision for artificial intelligence…
Novo Nordisk and Amazon have signed a partnership agreement focused on AI-driven drug discovery and announced…
Google and Cleveland Clinic announced a partnership to develop AI-powered robotic systems designed to improve…
Graph neural networks are being deployed to detect pharmaceutical counterfeiting and fraud by revealing hidden…
ServiceNow has announced AI-powered agents designed to operate within security operations centers (SOCs), auto…
The AI news that matters, in one minute each morning.
Sign up free